The appointment marks a key milestone in the company’s growth strategy and comes at a time of increasing momentum. Dr Harris will formally take on the role of Non-Executive Chairman from 1 July 2025.

Dr Harris is a highly regarded investment banker and corporate strategist with over 35 years of experience advising on complex cross-border M&A, equity and debt capital markets transactions, and corporate leadership.

He has held senior roles at Morgan Grenfell, Drexel Burnham, and served as Chief Executive of HSBC Investment Bank. Dr Harris was also the principal owner and Chairman of Seymour Pierce Holdings and has held a number of high-profile board positions, including Chairman of Wembley National Stadium, and the Football League.

He currently serves as Chairman of NASDAQ-listed gene therapy company MeiraGTx and Executive Chairman of Global Connectivity Plc, quoted on AQSE.

Dr Harris’s deep expertise in capital markets will be instrumental as IntelliAM accelerates its growth and explores strategic opportunities in the UK and internationally.

Commenting on the appointment, Tom Clayton, CEO of IntelliAM, said:

“We are delighted to welcome Keith to the board. His extraordinary track record in capital markets and board leadership will bring enormous value to IntelliAM as we deepen our relationships with institutional investors and pursue our strategic growth initiatives.”

Dr Harris, Chairman-Elect, added:

“IntelliAM is delivering real transformation in a vital sector through the intelligent application of AI. I look forward to working with Tom and the board to support the company’s ambitions and help realise its significant market potential.”